Martine CAROFF received the European prize for Women Innovators 2019 during the VIVA Technology meeting in Paris. The prize rewards Martine for her scientific career and innovations that enabled the creation of 2 companies, LPS-BIOSCIENCES and HEPHAISTOS-Pharma.
Martine has been selected as finalist of the European Prize for Woman Innovators 2019.
retweet @ EU_H2020: RT EUScienceInnov: "Never give up, believe in yourself, work a lot & make your dreams come true. Yes, Women can," says Martine Caroff, finalist for #WiPrizeEU, co-founder of LPSBioSciences, biotech company specialised in endotoxins fo… pic.twitter.com/txHzM0Imfs
— eoservices (@eo_services) 11 avril 2019
LPS-BIOSCIENCES is glad to welcome Tatiana KONDAKOVA, PhD, as the new Vaccine Group Leader.
She obtained her PhD in Cell Biology in the Laboratory of Microbiology Signals and Microenvironment at the University of Rouen, France (2012-2015) in collaboration with the Centre Régional d’Innovation et de Transfert Technologique (CERTAM) by working on airborne bacteria, and specializing in analysis of bacterial membrane lipids. Interested by this topic, she joined the Cronan Lab at the University of Illinois, USA (2016-2018) for studying the regulation of bacterial lipid biosynthesis, using genomics and biochemical tools.
Martine Caroff, DSc, will represent LPS-BIOSCIENCES at the 12th Bordetelles International Symposium in Brussels, Belgium, from 9 to 12 April 2019, presenting with Alexey Novikov a poster titled "AN UPDATE ON THE BORDETELLAENDOTOXINS SAGA", a summary of the results of 40 years of research and our latest developments on the endotoxins of this bacterial genus to which B. pertussis and B. parapertussis, whooping cough agents, belong.
-A comparative study of the complete lipopolysaccharide structures and biosynthesis loci of Bordetella avium, B. hinzii, and B. trematum
Alexey Novikov, Nico Marr and Martine Caroff
Biochimie, (2019) doi: 10.1016/j.biochi.2018.12.011.
Meet us at the poster session and discuss our latest innovations in LPS production for using LPS in vaccine development or in sepsis in vivo models.